Cargando…
Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera
Genetic studies in the past decade have improved our understanding of the molecular basis of the BCR-ABL1-negative myeloproliferative neoplasm (MPN) polycythaemia vera (PV). Such breakthroughs include the discovery of the JAK2V617F driver mutation in approximately 95% of patients with PV, as well as...
Autores principales: | Stuckey, Ruth, Gómez-Casares, María Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126083/ https://www.ncbi.nlm.nih.gov/pubmed/34068690 http://dx.doi.org/10.3390/ijms22095042 |
Ejemplares similares
-
Koilonychia and Polycythæmia Vera
por: Glazebrook, A. J.
Publicado: (1944) -
Unusual Neurological Symptoms in Polycythæmia Rubra Vera
por: Grunberg, A., et al.
Publicado: (1950) -
Haemoglobinopathia Ypsilanti – A rare, but important differential diagnosis to polycythaemia vera()
por: Nygaard, Marietta, et al.
Publicado: (2013) -
Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
por: Amé, Shanti, et al.
Publicado: (2023) -
Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera
por: Tiong, I S, et al.
Publicado: (2016)